Anastomosis Devices Market Overview:
According to Research by SNS Insider, The global Anastomosis Devices Market was valued at USD 3.61 billion in 2023, is poised to reach USD 6.63 billion by 2032, expanding at a steady CAGR of 7.01% during the forecast period of 2024 to 2032, according to the latest analysis by SNS Insider. This market growth is underpinned by an increasing number of surgical procedures worldwide, the growing burden of chronic diseases, and continuous innovations in minimally invasive surgical technologies.
Growth Drivers Powering Market Expansion
A key catalyst for the growth of the anastomosis devices market is the surge in major surgical procedures, currently estimated at 310 million annually, with the United States alone accounting for 40 to 50 million of these operations. A rising elderly population coupled with the prevalence of lifestyle-related diseases, including cardiovascular conditions and cancers, is significantly contributing to this surgical demand.
Get a Free Sample Report of Anastomosis Devices Market@ https://www.snsinsider.com/sample-request/4906
Chronic illnesses continue to impose a global health burden. Cardiovascular diseases remain the world’s leading cause of death, responsible for approximately 17.9 million deaths annually. In parallel, nearly 20 million new cancer cases are reported each year. These conditions frequently necessitate surgical intervention, where anastomosis devices play a vital role in tissue connection and wound healing. This strong correlation between chronic disease prevalence and the need for surgical devices underlines the enduring and growing demand for anastomosis solutions.
Technological advancements are transforming the surgical landscape. Innovations such as automated suturing systems, robotic-assisted procedures, and magnetic compression anastomosis are improving surgical precision, reducing postoperative complications, and expediting patient recovery times. These improvements are making advanced anastomosis devices more attractive to healthcare providers seeking better patient outcomes and cost efficiency.
Furthermore, the global shift toward value-based care and enhanced healthcare quality is intensifying focus on surgical outcomes. Hospitals and surgical centers increasingly prioritize tools that deliver higher success rates and fewer complications, which supports the uptake of high-performance anastomosis devices.
Market Segmentation Insights
By Product
Disposable Anastomosis Devices
Disposable devices led the market in 2023, capturing over 60% of the global share. Their appeal lies in single-use convenience, sterility, and compliance with infection control protocols. With rising concerns over hospital-acquired infections, disposable solutions are becoming the standard, particularly in cardiovascular and gastrointestinal surgeries.
Reusable Anastomosis Devices
While still emerging, reusable devices are the fastest-growing product segment, projected to grow at a CAGR of 10%. These devices offer long-term cost savings and environmental benefits. Advances in materials and design have enhanced their durability and usability, making them increasingly attractive in high-volume surgical facilities.
By Application
Cardiovascular Surgery
This application segment dominated in 2023, accounting for over 40% of total market revenue. The prevalence of cardiovascular conditions and increasing demand for procedures like coronary artery bypass grafting (CABG) drive sustained demand for precise and reliable anastomosis tools.
Gastrointestinal Surgery
The fastest-growing segment, gastrointestinal surgery is projected to grow at 12% annually. The segment is buoyed by rising incidences of GI disorders and the popularity of bariatric surgeries. As outpatient care expands and recovery times are prioritized, the need for minimally invasive and effective anastomosis techniques is on the rise.
Regional Overview
North America
North America led the market in 2023 with over 40% share, largely due to its advanced healthcare infrastructure, high surgical volumes, and rapid adoption of innovative medical devices. The United States continues to invest heavily in R&D, with a particular focus on robotic and minimally invasive technologies.
Europe
Europe accounts for approximately 30% of global revenue, with robust demand from countries like Germany, France, and the UK. A strong regulatory framework, high public health awareness, and increasing investment in surgical innovation are key growth drivers in this region.
Asia-Pacific (APAC)
APAC is the fastest-growing regional market, with an anticipated CAGR of 10%. Increasing access to healthcare, rising surgical volumes, and growing healthcare investments in China, India, and Japan are fueling market acceleration. A burgeoning middle class and growing awareness of advanced surgical procedures further contribute to the region’s rapid market expansion.
Buy a Single-User PDF of Anastomosis Devices Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/4906
Key Market Players
Leading manufacturers continue to invest in R&D and expand their product portfolios to strengthen their market positions. Notable companies include:
- Johnson & Johnson (Ethicon, Inc.) – Endo Stitch, Proximate Staplers
- Medtronic Plc – HeartString Proximal Anastomosis System, Tri-Staple
- B. Braun Melsungen AG – Gastrointestinal and Vascular Suturing Devices
- Intuitive Surgical Inc. – da Vinci Surgical Systems, EndoWrist Stapler
- Artivion, Inc. – Cardio-PA, Anastomosis Systems
- Mizuho Medical Co., Ltd – Vascular Anastomosis Solutions
- Getinge AB – FlowSurgical Anastomosis System
- Peters Surgical – Sutures and Staplers
- Baxter International Inc. – BioSuture Stapler
- Vascular Graft Solutions Ltd. – Specialty Vascular Products
- Medline Industries, LP – Surgical Suturing and Stapling Systems
- Seger Surgical Solutions – Specialty Suturing Devices
- LivaNova PLC – Coronary Anastomosis Devices
- MAQUET Holding – TA Staplers and Anastomosis Systems
- Novare Surgical Systems – Suturing and Anastomosis Kits
- Vitalitec International – Vascular Anastomosis Products
Recent Developments
- November 2024: GI Windows Surgical raised USD 37 million to advance its Flexagon magnetic anastomosis platform. This minimally invasive system aims to revolutionize tissue fusion through self-forming magnet technology.
- September 2024: GT Metabolic Solutions received FDA de novo clearance for its MagDI system—a first-generation side-to-side duodeno-ileal magnetic compression anastomosis device. The system enables incision-less procedures with reduced technical variability and eliminates retained foreign materials.
Future Outlook
The anastomosis devices market is entering a transformative era as demand for surgical solutions rises globally. The confluence of rising surgical volumes, technological breakthroughs, and heightened focus on patient safety and outcomes is setting the stage for strong long-term growth.
As healthcare systems across the world prioritize innovation and cost-efficiency, companies operating in this space must continue to develop reliable, minimally invasive, and cost-effective solutions. The expanding demand for both disposable and reusable options further opens up new opportunities for device manufacturers to capture value in this evolving landscape.
Read Our Other Report
Ostomy Care and Accessories Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
